Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;86(4):1917-1933.
doi: 10.3233/JAD-215059.

A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes

Affiliations

A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes

Steven R Alves et al. J Alzheimers Dis. 2022.

Abstract

Background: Increasing evidence links impaired brain insulin signaling and insulin resistance to the development of Alzheimer's disease (AD).

Objective: This evidence prompted a search for molecular players common to AD and diabetes mellitus (DM).

Methods: The work incorporated studies based on a primary care-based cohort (pcb-Cohort) and a bioinformatics analysis to identify central nodes, that are key players in AD and insulin signaling (IS) pathways. The interactome for each of these key proteins was retrieved and network maps were developed for AD and IS. Synaptic enrichment was performed to reveal synaptic common hubs.

Results: Cohort analysis showed that individuals with DM exhibited a correlation with poor performance in the Mini-Mental State Examination (MMSE) cognitive test. Additionally, APOE ɛ2 allele carriers appear to potentially be relatively more protected against both DM and cognitive deficits. Ten clusters were identified in this network and 32 key synaptic proteins were common to AD and IS. Given the relevance of signaling pathways, another network was constructed focusing on protein kinases and protein phosphatases, and the top 6 kinase nodes (LRRK2, GSK3B, AKT1, EGFR, MAPK1, and FYN) were further analyzed.

Conclusion: This allowed the elaboration of signaling cascades directly impacting AβPP and tau, whereby distinct signaling pathway play a major role and strengthen an AD-IS link at a molecular level.

Keywords: Alzheimer’s disease; apolipoprotein E; insulin; leucine-rich repeat serine-threonine protein kinase-2; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

Authors’ disclosures available online (https://www.j-alz.com/manuscript-disclosures/21-5059r2).

Figures

Fig. 5
Fig. 5
Signaling pathways towards AβPP phosphorylation. Graphical view of signaling pathways of the top 6 proteins with higher betweenness centrality values from Fig. 4 towards AβPP using the kinector tool. 1) LRRK2 signaling pathway towards AβPP. 2) GSK3B signaling pathway towards AβPP. 3) AKT1 signaling pathway towards AβPP. 4) EGFR signaling pathway towards AβPP. 5) ERK2 signaling pathway towards APP. 6) FYN signaling pathway towards AβPP.
Fig. 6
Fig. 6
Signaling pathways towards tau phosphorylation. Graphical view of signaling pathways of the top 6 proteins with higher betweenness centrality values from Fig. 4 towards tau using the kinector tool. 1) LRRK2 signaling pathway towards tau. 2) GSK3B signaling pathway towards tau. 3) AKT1 signaling pathway towards tau. 4) EGFR signaling pathway towards tau. 5) ERK2 signaling pathway towards tau. 6) FYN signaling pathway towards tau.
Fig. 1
Fig. 1
Synaptic AD/IS coincident network. Representation of all proteins retrieved from the interception between Alzheimer’s disease (AD), insulin signaling (IS), and the synapse. Community cluster (GLay) from ClusterMaker 2.0 was used to create the communities. Node size increases with higher values of betweenness centrality. A) Each community/cluster is highlighted in a different color. Key AD proteins are marked with a black circumference, key IS proteins with a dark grey circumference, and nodes common to both with a red circumference. B) Network with kinases filled in red, catalytic subunits of protein phosphatases filled in green and genetic risk factors for AD marked with a black circumference. Clusters are numbered left to right, top panel (clusters 1 to 4) and bottom panel (clusters 5 to 10), several proteins (102) are not integrated into clusters.
Fig. 2
Fig. 2
Cluster analysis. A) Absolute number of nodes with characteristics as indicated for each cluster. B) Different node characteristics represented as a percentage of nodes within each cluster and as a total of the synaptic AD and IS coincident network. Cluster 9 and 10 were excluded since no relevant nodes were present. OC, outside of the clusters.
Fig. 3
Fig. 3
Gene ontology analyses. Graphical representation of the distribution of the genes in the ‘Synaptic AD/IS coincident network’ with respect to cellular component, biological process, and molecular function. Top 12 hits are indicated.
Fig. 4
Fig. 4
AD/IS synaptic kinase and phosphatase network. Color code obeys the communities presented in Fig. 1A. Node size increases with higher values of betweenness centrality. Kinases are highlighted with a dark red border and catalytic subunits of protein phosphatases are highlighted with a green border.

References

    1. Hoyer S (1970) Der Aminosäuren-Stoffwechsel des normalen menschlichen Gehirns. Klin Wochenschr 48, 1239–1243. - PubMed
    1. Hoyer S (1991) Abnormalities of glucose metabolism in Alzheimer’s disease. Ann N Y Acad Sci 640, 53–58. - PubMed
    1. Talbot K, Wang H-Y, Kazi H, Han L-Y, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE (2012) Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122, 1316–38. - PMC - PubMed
    1. Duelli R, Schröck H, Kuschinsky W, Hoyer S (1994) Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci 12, 737–743. - PubMed
    1. Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y (2020) Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease. Mol Neurodegener 15, 40. - PMC - PubMed

Publication types